These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27750024)

  • 21. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroglobulin - what is the postoperative threshold for the suspicion of thyroid cancer recurrence in the absence of anti-Tg antibody measurement?
    Papageorgiou MS; Liratzopoulos N; Minopoulos G; Manolas KJ
    S Afr J Surg; 2011 Aug; 49(3):118-22. PubMed ID: 21933495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
    d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
    Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine.
    Zhang X; Higuchi T; Tomonaga H; Lamid-Ochir O; Bhattarai A; Nguyen-Thu H; Taketomi-Takahashi A; Hirasawa H; Tsushima Y
    Nucl Med Commun; 2020 Apr; 41(4):350-355. PubMed ID: 32032192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival.
    Piccardo A; Arecco F; Puntoni M; Foppiani L; Cabria M; Corvisieri S; Arlandini A; Altrinetti V; Bandelloni R; Orlandi F
    Clin Nucl Med; 2013 Jan; 38(1):18-24. PubMed ID: 23242039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
    Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
    Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend.
    Malandrino P; Tumino D; Russo M; Marescalco S; Fulco RA; Frasca F
    J Endocrinol Invest; 2019 Oct; 42(10):1223-1230. PubMed ID: 30963467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
    Zhao T; Liang J; Guo Z; Li J; Lin Y
    Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants?
    Zhao T; Liang J; Li T; Guo Z; Vinjamuri S; Lin Y
    Nucl Med Commun; 2016 Jun; 37(6):632-9. PubMed ID: 26829063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.
    Chao M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
    Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
    Zöphel K; Wunderlich G; Smith BR
    Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
    Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer.
    Giovanella L; Imperiali M; Trimboli P
    Sci Rep; 2017 Aug; 7(1):7359. PubMed ID: 28779086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.